On August 25, 2019, the 2019 (36th) National Medicinal Industry Information Annual Conference, sponsored by China Pharmaceutical Industry Information Center, opened grandly in Lianyungang. The conference released the list of top 100 enterprises in China’s pharmaceutical industry in 2018. China Grand Enterprises ranked the 13th in the list again with its strength, representing that its excellent achievements in the field of medicine and health in recent years have been continuously recognized.

China Grand Enterprises Pharmaceuticals and Healthcare (hereinafter referred to as CGE Healthcare) has established several core industrial platforms within her controlled subsidiary companies, which include Huadong Medicine, Grand Pharmaceutical Group, Lei Yunshang Pharmaceutical Group and Grand Biotech Group. The group owns more than 500 patents, one state-classified formula, 1,045 registered products, and 47 exclusive products. The sales network spreads all over the world. It has developed and maintained close collaborations with over 10,000 second-tier or above hospitals, 40,000 plus primary healthcare facilities and top 100 chain drugstores nationwide, which supports the fast development of the enterprise.

CGE Healthcare is committed to adhere to the business principle of being research-oriented, customer-focused and market-driven, and has always taken innovation as its strategic focus. Through the construction of independent research and development platform, industry-university-research collaborative innovation and international cooperation, it has continuously put new products into market, providing guarantee for the high-speed sustainable development of the enterprise. CGE Healthcare has built a comprehensive business model in her pharmaceuticals and healthcare industry that integrates R&D, production and distribution. Focusing on both domestic and global markets, CGE Healthcare has developed a business model to combine traditional Chinese and Western medicines.

In the future, China Grand Enterprises will continue to adhere to the principle of quality first, seek development through innovation, regard “serving the society” as its highest mission, establish future business through innovative cooperation, and make continuous contributions to the society.